Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2007
08/30/2007US20070203136 Triazolopyridazines as kinase modulators
08/30/2007US20070203135 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists
08/30/2007US20070203116 2'-amino-2-methoxy-1,1'-dimethyl-7-bromo-10,11-dihydrospiro[dibenzo[a,d][7]-annulene-5,4'-imidazol]-5'(1'H)-one; treatment of beta -amyloid deposits and neurofibrillary tangles; useful in treating Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy
08/30/2007US20070203072 Hcv Ns-3 Serine Protease Inhibitors
08/30/2007DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
08/30/2007CA2643668A1 Salt of cd 80 antagonist
08/30/2007CA2642762A1 Pyrrolidine derivatives as erk inhibitors
08/30/2007CA2642610A1 Amide derivative or salt thereof
08/29/2007EP1824856A1 2,4 (4,6) pyrimidine derivatives
08/29/2007EP1824855A1 Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy
08/29/2007EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
08/29/2007EP1824820A2 Substituted tetracyclic tetrahydrofuran,pyrrolidine and tetrahydrothiophene derivatives
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/29/2007EP1121361B1 Pyrazolo-triazine derivatives as ligands for gaba receptors
08/29/2007CN101027306A Method of preparing poly(ADP-ribose) polymerases inhibitors
08/29/2007CN101027305A Fused heterocyclic kinase inhibitors
08/29/2007CN101027304A Synthesis of 6,7-dihydro-5H-imidazo[1,2-A]imidazole-3-sulfonic acid amides
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/29/2007CN101027060A Quinazoline derivatives and their use in the treatment of thrombocythemia
08/29/2007CN101027055A Tricycles, their manufacture and use as pharmaceutical agents
08/29/2007CN101024645A Method for recovering hexamethylenetetramine and amino acetic acid from amino acetic acid dealcoholed mother liquid
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN100334088C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
08/28/2007US7262302 Antiinflammatory action; rheumatoid arthritis
08/28/2007US7262297 For lowering blood glucose
08/28/2007US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
08/28/2007US7262199 Tyrosine kinase inhibitors
08/28/2007US7262195 Compounds useful as motilin agonists and method
08/28/2007US7262192 Such as 1-(2-ethoxyethyl)-3-methyl-5-[(3R)-3-methylpiperazin-1-yl]-N-pyrimidin-4-yl-1H-pyrazolo[4,3-d]pyrimidin-7-amine; cyclic-guanosine monophosphate phosphodiesterase inhibitors
08/28/2007US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor
08/28/2007US7262186 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl0-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide
08/28/2007CA2265874C Condensed n-acylindoles as antitumor agents
08/23/2007WO2007095632A1 Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
08/23/2007WO2007095588A1 Pi-3 kinase inhibitors and methods of their use
08/23/2007WO2007095423A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/23/2007WO2007094325A1 Novel fluorescent substance having benzimidazole skeleton and use thereof
08/23/2007WO2007093520A1 Hetero-bycyclic antiviral compounds
08/23/2007WO2007093515A1 Heterocyclic antiviral compounds
08/23/2007WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007076085A3 Fused pyrimidones and thiopyrimidones, and uses thereof
08/23/2007WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
08/23/2007WO2006081388A3 Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
08/23/2007US20070197798 Process for producing cyclic n-hydroxy imide compounds
08/23/2007US20070197787 Heat shock protein 90 inhibitors
08/23/2007US20070197781 Processes for the preparation of carbapenems
08/23/2007US20070197616 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
08/23/2007US20070197608 Piperazines as oxytocin agonists
08/23/2007US20070197565 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
08/23/2007US20070197564 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
08/23/2007US20070197561 Inhibitors of nucleoside metabolism
08/23/2007US20070197559 Aryl substituted purine analogues
08/23/2007US20070197558 Anti-viral compounds
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197549 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/23/2007US20070197540 Pyrazolopyrimidines
08/23/2007US20070197539 Hexahydro-pyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids
08/23/2007US20070197535 Polymorphic forms of vardenafil
08/23/2007US20070197527 Bicyclic heteroaromatic compounds
08/23/2007US20070197511 Neuroprotective bicyclic compouds and methods for their use
08/23/2007US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient
08/23/2007US20070197507 N-Heteroaryl-N'-(1-(piperazin-1-yl)-6 or 7-indanyl)ureas, e.g., methyl 4-(6-{[(6-methyl-3-pyridyl)amino]carbonylamino}indanyl)piperazinecarboxylate and N-{3-[4-(ethylsulfonyl)piperazinyl]indan-5-yl}[(6-methyl(3-pyridyl))amino]carboxamide; cardiac myosin potentiators; treating congestive heart failure
08/23/2007US20070197496 for modulating cellular levels of oxidants such as superoxide radicals, hydrogen peroxide, peroxynitrite, lipid peroxides, hydroxyl radicals and thiyl radicals, treating diabetes mellitus Type I or Type II
08/23/2007US20070197482 Regulation of guanine nucleotide exchange factor for a protein belonging to the rap family of small gtpases
08/23/2007US20070197389 Azolopyrimidine compounds and use thereof for combating parasitic fungi
08/23/2007US20070196270 Compounds As Ccri Antagonists
08/23/2007US20070194698 Charge transport compositions and electronic devices made with such compositions
08/23/2007DE102006007621A1 Diketopyrrolopyrrol-Pigmente mit erhöhten Echtheiten und Verfahren zu deren Herstellung Diketopyrrolopyrrole pigments with increased fastness properties and processes for their preparation
08/23/2007CA2642738A1 Pi-3 kinase inhibitors and methods of their use
08/23/2007CA2642205A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/23/2007CA2641389A1 Hetero-bycyclic antiviral compounds
08/23/2007CA2641382A1 Heterocyclic antiviral compounds
08/23/2007CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1819709A1 Novel diazabicyclic aryl derivatives as cholinergy ligands
08/22/2007EP1819697A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
08/22/2007EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors
08/22/2007EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof
08/22/2007EP1756052A4 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
08/22/2007EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/22/2007EP1499320B1 Novel compounds
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS
08/22/2007EP1067138B1 Hydroxyproline derivatives
08/22/2007CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion
08/22/2007CN1332950C Improved compounds for generating chemiluminescence with peroxidase
08/22/2007CN1332658C Antibacterial compositions comprising metal phthalocyanine analogues
08/22/2007CN101023084A Compositions containing phthalocyanine dyes
08/22/2007CN101023083A Nitrogenous fused bicyclic compound
08/22/2007CN101023074A Inhibitors of the interaction between MDM2 and P53
08/22/2007CN101020702A Synthesis process of desulfurizing catalyst of hexamino binuclear phthalocyanine and its derivative
08/21/2007US7259167 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
08/21/2007US7259165 especially 3-sulfonylpyrazolo[4.3b]pyridines and 3-sulfonylpyrrolo[3.2b] and [2.3b]pyridines; treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor, such as attention deficit disorder; obsessive compulsive disorder; and withdrawal from drug, alcohol or nicotine
08/21/2007US7259164 Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
08/21/2007US7259160 Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
08/21/2007US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/21/2007US7259154 Pyrrolopyrimidines
08/21/2007CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
08/16/2007WO2007092888A2 Hcv ns5b inhibitors
08/16/2007WO2007092727A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 573